Cognitive, neuropsychiatric and quality-of-life sequelae in LGI1-antibody disease demonstrates fatigue as the key determinant of wellbeing
| Autors principals: | , , , , , , , , , |
|---|---|
| Format: | Conference item |
| Idioma: | English |
| Publicat: |
Wiley
2020
|